Publications
5803 Results
- Journal / Conference
- Clinical Lung Cancer Jan;23(1):60-71
- Year
- 2022
- Research Committee(s)
- Lung
- PMID
- PMID34753703
- PMC
- PMC8766941
- Study Number(s)
- S0819
EGFR High Copy Number Together with High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis from SWOG S0819, a phase III trial of chemotherapy with or without Cetuximab in advanced NSCLC
- Journal / Conference
- Oncogene Jan;41(2):260-267
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34728807
- PMC
- PMC8738154
- Study Number(s)
- CTSU/C80405
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
- Journal / Conference
- Journal of Geriatric Oncology, Mar;13(2):258-264
- Year
- 2022
- Research Committee(s)
- Lymphoma
- PMID
- PMID34686472
- PMC
- PMC9879719
- Study Number(s)
- S1918
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool
- Journal / Conference
- Clinical Cancer Research Feb 15;28(4):611-617
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID34844978
- PMC
- PMC9782801
- Study Number(s)
- S1222
A randomized trial of fulvestrant, everolimus and anastrozole in the front line treatment of advanced hormone receptor positive breast cancer, SWOG S1222
- Journal / Conference
- Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
- Year
- 2022
- Research Committee(s)
- Cancer Control
- PMID
- PMID34889205
- PMC
- PMC8776589
- Study Number(s)
- SWOG-9217
Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of the National Cancer Institute Mar 8;114(3):372-380; Jan 4;djab210. doi: 10.1093/jnci/djab210. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID34981117
- PMC
- PMC8902339
- Study Number(s)
- S1417CD
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients
- Journal / Conference
- European Urology May;81(5):458-462
- Year
- 2022
- Research Committee(s)
- Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID35031163
- PMC
- PMC9018520
- Study Number(s)
- S0000, SWOG-9217
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S1922
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma: SWOG S1922
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2104
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104
- Journal / Conference
- Am J Clin Nutr. 2022 Apr 1;115(4):1205-1216
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID35040869
- PMC
- PMC8970985
- Study Number(s)
- S0000C